Biomerica, Inc. (BMRA) vs Cytosorbents Corporation (CTSO)
Biomerica, Inc. and Cytosorbents Corporation are both Medical Devices companies. Cytosorbents Corporation is the larger, with a market value of $13.6M against $11.3M — 1.2× the size. Cytosorbents Corporation grew revenue faster over the last twelve months: 3.07% against −16.2%. Cytosorbents Corporation has the higher net margin (−48.9% vs −84.8%) and the higher return on invested capital (−66.9% vs −251.5%). Across the 17 metrics below, Cytosorbents Corporation leads on 13 and Biomerica, Inc. on 4.
Valuation
Profitability
| Metric | BMRA | CTSO | Medical Devices median |
|---|---|---|---|
| Gross margin | 8.13% | 71.61% | 56.01% |
| Operating margin | (119.47%) | (34.74%) | (15.03%) |
| Net margin | (84.77%) | (48.94%) | (20.40%) |
| Free cash flow margin | (76.94%) | (25.32%) | (7.24%) |
| Return on equity | (112.10%) | (336.17%) | (15.32%) |
| Return on assets | (59.43%) | (42.38%) | (19.72%) |
| Return on invested capital | (251.51%) | (66.90%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack